Magdy
El-Salhy
Adjunct Professor
Visit Address:
Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
5021 Bergen
Postal Address:
Postboks 7804
5021 Bergen
E-mail:
Books
- 2012. Irritable Bowel Syndrome: Diagnosis, Pathogenesis and Treatment Options. Nova Science Publishers, Inc.. 148 pages. ISBN: 9781620815526.
Journal articles
- 2014. Endocrine cells in the ileum of patients with irritable bowel syndrome. World Journal of Gastroenterology. 20: 2383-2391. doi: 10.3748/wjg.v20.i9.2383
- 2014. Duodenal Chromogranin A Cell Density as a Biomarker for the Diagnosis of Irritable Bowel Syndrome. Gastroenterology Research and Practice. 2014. 8 pages. doi: 10.1155/2014/462856
- 2014. Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (Review). International Journal of Molecular Medicine. 34: 363-371. doi: 10.3892/ijmm.2014.1811
- 2014. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome. Tidsskrift for Den norske legeforening. 6: 176-185. doi: 10.4253/wjge.v6.i5.176
- 2014. Stomach antral endocrine cells in patients with irritable bowel syndrome. International Journal of Molecular Medicine. 34: 967-974. doi: 10.3892/ijmm.2014.1887
- 2014. Chromogranin A cells in the stomachs of patients With sporadic irritable bowel syndrome. Molecular Medicine Reports. 10: 1753-1757. doi: 10.3892/mmr.2014.2472
- 2014. Is irritable bowel syndrome an organic disorder? World Journal of Gastroenterology. 20: 384-400. doi: 10.3748/wjg.v20.i2.384
- 2014. Abnormal rectal endocrine cells in patients with irritable bowel syndrome. Regulatory Peptides. 188: 60-65. doi: 10.1016/j.regpep.2013.11.005
- 2014. Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. Expert Review of Gastroenterology & Hepatology. 8: 435-443. doi: 10.1586/17474124.2014.888952
- 2014. Chronic constipation and treatment options (Review). Molecular Medicine Reports. 9: 3-8. doi: 10.3892/mmr.2013.1770
- 2014. Amelioration of Severe TNBS Induced Colitis by Novel AP-1 and NF-κB Inhibitors in Rats. Scientific World Journal. 2014. 8 pages. doi: 10.1155/2014/813804
- 2014. Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome. European Journal of Clinical Nutrition. doi: 10.1038/ejcn.2014.151
- 2013. Clinical presentation, diagnosis, pathogenesis and treatment options for lymphocytic colitis (Review). International Journal of Molecular Medicine. 32: 263-270. doi: 10.3892/ijmm.2013.1385
- 2013. Low‑grade inflammation in the rectum of patients with sporadic irritable bowel syndrome. Molecular Medicine Reports. 7: 1081-1085. doi: 10.3892/mmr.2013.1320
- 2013. Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report. BMC Research Notes. 6. 11 pages. doi: 10.1186/1756-0500-6-391
- 2013. The role of peptide YY in gastrointestinal diseases and disorders (Review). International Journal of Molecular Medicine. 31: 275-282. doi: 10.3892/ijmm.2012.1222
- 2013. Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease. Molecular Medicine Reports. 8: 451-455. doi: 10.3892/mmr.2013.1525
- 2013. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome. Molecular Medicine Reports. 7: 1241-1244. doi: 10.3892/mmr.2013.1325
- 2013. Colonoscopy with mucosal biopsies in young rats: A model for experimental gastroenterology. Molecular Medicine Reports. 7: 1757-1760. doi: 10.3892/mmr.2013.1422
- 2013. Evaluation of the usefulness of colonoscopy with mucosal biopsies in the follow-up of TNBS-induced colitis in rats. Molecular Medicine Reports. 8: 446-450. doi: 10.3892/mmr.2013.1528
- 2013. Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Molecular Medicine Reports. 8: 845-852. doi: 10.3892/mmr.2013.1565
- 2013. Increased serotonin transporter immunoreactivity intensity in the ileum of patients with irritable bowel disease. Molecular Medicine Reports. 9: 180-184. doi: 10.3892/mmr.2013.1784
- 2012. Irritable bowel syndrome: Diagnosis and pathogenesis. World Journal of Gastroenterology. 18: 5151-5163. doi: 10.3748/wjg.v18.i37.5151
- 2012. Irritable bowel syndrome: treatment options. Clinical Practice. 9: 591-600. doi: 10.2217/cpr.12.41
- 2012. High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis. World Journal of Gastroenterology. 18: 6070-6075. doi: 10.3748/wjg.v18.i42.6070
- 2012. Chromogranin A cell density as a diagnostic marker for lymphocytic colitis. Digestive Diseases and Sciences. 57: 3154-3159. doi: 10.1007/s10620-012-2249-6
- 2012. Low Densities of Serotonin and Peptide YY Cells in the Colon of Patients with Irritable Bowel Syndrome. Digestive Diseases and Sciences. 57: 873-878. doi: 10.1007/s10620-011-1948-8
- 2012. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. Molecular Medicine Reports. 6: 1223-1225. doi: 10.3892/mmr.2012.1087
- 2012. Irritable bowel syndrome: the role of gut neuroendocrine peptides. Frontiers in Bioscience (Elite Edition). 4: 2783-2800. doi: 10.2741/583
- 2012. The role of diet in the pathogenesis and management of irritable bowel syndrome (Review). International Journal of Molecular Medicine. 29: 723-731. doi: 10.3892/ijmm.2012.926
- 2012. Ghrelin and the brain-gut axis as a pharmacological target for appetite control. Current pharmaceutical design. 18: 768-775. doi: 10.2174/138161212799277806
- 2012. Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Molecular Medicine Reports. 5: 1382-1390. doi: 10.3892/mmr.2012.843
- 2011. Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. International Journal of Molecular Medicine. 28: S10-S10.
- 2011. The prevalence of inflammatory bowel diseases, microscopic colitis, and colorectal cancer in patients with irritable bowel syndrome. Gastroenterology Insights. 3: 7-10. doi: 10.4081/gi.2011.e3
- 2011. The prevalence of celiac disease in patients with irritable bowel syndrome. Molecular Medicine Reports. 4: 403-405. doi: 10.3892/mmr.2011.466
- 2011. High chromogranin A cell density in the colon of patients with lymphocytic colitis. Molecular Medicine Reports. 4: 603-605. doi: 10.3892/mmr.2011.492
- 2010. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Alimentary Pharmacology and Therapeutics. 31: 883-891. doi: 10.1111/j.1365-2036.2010.04251.x
- 2010. Effects of a health program comprising reassurance, diet management, probiotics administration and regular exercise on symptoms and quality of life in patients with irritable bowel syndrome. Gastroenterology Insights. 2: 21-26. doi: 10.4081/gi.2010.e6
- 2010. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. Scandinavian Journal of Gastroenterology. 45: 1435-1439. doi: 10.3109/00365521.2010.503965
- 2010. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. Digestive Diseases and Sciences. 55: 3508-3513. doi: 10.1007/s10620-010-1169-6
- 2009. Ghrelin in gastrointestinal diseases and disorders: A possible role in the pathophysiology and clinical implications (Review). International Journal of Molecular Medicine. 24: 727-732. doi: 10.3892/ijmm_00000285
- 2009. Ghrelin in patients with irritable bowel syndrome. International Journal of Molecular Medicine. 23: 703-707. doi: 10.3892/ijmm_00000183
- 2009. Low density of ghrelin cells in the oxyntic mucosa correlated to slow gastric emptying in patients with diabetes type 1. International Journal of Molecular Medicine. 24: S73-S73.
- 2009. Low density of ghrelin cells in the oxyntic mucosa correlated to slow gastric emptying in patients with type 1 diabetes. Molecular Medicine Reports. 2: 893-896. doi: 10.3892/mmr_00000188
Book sections
- 2013. Diet and Irritable Bowel Syndrome, with a Focus on Appetite-Regulating Gut Hormones. Chapter 1, pages 5-17. In:
- 2013. Nutrition in the Prevention and Treatment of Abdominal Obesity. Elsevier. 529 pages. ISBN: 978-0-12-407869-7.
More information in national current research information system (CRIStin)
